Etizolam is a thienodiazepine that is chemically related to benzodiazepine (BDZ) drug class; it differs from BDZs in having a benzene ring replaced with a thiophene ring. It is an agonist at GABA-A receptors and possesses amnesic, anxiolytic, anticonvulsant, hypnotic, sedative and skeletal muscle relaxant properties. Initially introduced in 1983 in Japan as treatment for neurological conditions including anxiety and sleep disorders, etizolam is marketed in Japan, Italy and India. It is not approved for use by FDA in the US; however it remains unscheduled in several states and is legal for research purposes. It is grouped under the following drug class(es): Anxiolytics, Benzodiazepines and Psychotropic agents. Its therapeutic use is listed as antianxiety drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Depas, Etizolamum and Sedekopan. It is listed as a controlled drug substance (Schedule I). Its PubChem CID is 3307.
Etizolam
| CAS No | 40054-69-1 |
|---|---|
| Molecular Formula | C17H15ClN4S |
| Molecular Weight | 342.8 g/mol |
| Synonyms | 7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Etizolam is a thienodiazepine that is chemically related to benzodiazepine (BDZ) drug class; it differs from BDZs in having a benzene ring replaced with a thiophene ring.
The listed CAS number is 40054-69-1.
The listed molecular formula is C17H15ClN4S.
The listed molecular weight is 342.8 g/mol.
7-(2-chlorophenyl)-4-ethyl-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaene.
The source lists Depas, Etizolamum and Sedekopan.